LIXTE Biotechnology Sponsors Health Equity Summit at Morehouse College Focused on Black Men and Families

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) is sponsoring the inaugural Good Health: Mind, Body & Soul Summit, an invitation-only event scheduled for February 19 at Morehouse College in Atlanta. The Summit brings together leaders in health, culture, science, and community to advance health equity for Black men and families and is rooted in De La Soul's song "Good Health," written following the passing of founding member David Jolicoeur. Developed in collaboration with Blacksmith holdings, the program reflects De La Soul's evolution from musical pioneers to wellness advocates and will feature discussions spanning cancer, heart disease, mental health, addiction, sleep, relationships, and intergenerational wellness.

LIXTE stated the Summit aligns with its mission as a clinical-stage pharmaceutical company advancing cancer care through its first-in-class oncology compound LB-100 and its European research subsidiary, LIORA, while creating a space to connect scientific innovation with communities most impacted by health disparities. The company has demonstrated that its lead clinical PP2A inhibitor, LB-100, is well-tolerated in cancer patients at doses associated with anti-cancer activity. Based on extensive published preclinical data available at https://www.lixte.com, LB-100 has the potential to significantly enhance chemotherapies and immunotherapies and improve outcomes for patients with cancer.

LIXTE's lead compound, LB-100, is part of a pioneering effort in an entirely new field of cancer biology – activation lethality – that is advancing a new treatment paradigm. The company's new approach is covered by a comprehensive patent portfolio. Proof-of-concept clinical trials are currently in progress for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer. The sponsorship of the Morehouse College event represents a strategic alignment between LIXTE's scientific mission and broader public health initiatives addressing health disparities.

The Summit's focus on health equity for Black men and families comes at a critical time when health disparities continue to disproportionately affect minority communities. By sponsoring this event, LIXTE positions its cancer research within the context of comprehensive wellness that addresses multiple dimensions of health affecting underserved populations. The company's participation in this summit demonstrates how pharmaceutical innovation can intersect with community-based health initiatives to create more holistic approaches to healthcare.

This sponsorship represents a significant step in bridging the gap between clinical research and community health needs, particularly for populations that have historically faced barriers to quality healthcare. The event's comprehensive approach to wellness – addressing physical, mental, and social health factors – aligns with growing recognition in the medical community that effective healthcare must consider the whole person and their community context. LIXTE's involvement suggests a commitment to ensuring that advances in cancer treatment reach those who need them most while addressing the broader health challenges facing Black communities.